Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Elevance Health Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash and cash equivalents
Fixed maturity securities
Equity securities
Premium receivables, net
Self-funded receivables, net
Other receivables
Other current assets
Assets held for sale
Current assets
Fixed maturity securities
Other invested assets
Long-term investments
Property and equipment, net
Goodwill
Other intangible assets
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Overall, the company’s total assets exhibited a general upward trend throughout the observed period, from March 31, 2021, to December 31, 2025. However, the rate of growth varied, with periods of more rapid expansion followed by stabilization or slight declines. A significant portion of the asset base is consistently comprised of fixed maturity securities and goodwill.

Cash and Cash Equivalents
Cash and cash equivalents demonstrated considerable fluctuation. A decrease was observed from March 31, 2021, to December 31, 2021, followed by an increase peaking in September 2022. Subsequently, a decline occurred through December 2023, with a moderate recovery through June 2025. This suggests active cash management and potentially strategic deployment of funds.
Fixed Maturity Securities
Fixed maturity securities remained a substantial component of the asset base, generally ranging between US$25 billion and US$29 billion. A moderate increase was evident from March 2021 to December 2022, followed by a notable decrease in 2023 and early 2024. A slight recovery was observed in the latter part of the period, but values remained below the peak levels seen in 2022.
Equity Securities
Equity securities represented a smaller portion of total assets, with values generally below US$4 billion. A significant decrease occurred from March 2021 to December 2021, followed by a period of relative stability. A more pronounced increase was observed from March 2024 through September 2025, indicating a potential shift in investment strategy.
Receivables (Premium, Self-funded, Other)
Collectively, receivables constituted a significant portion of current assets. Premium receivables exhibited an increasing trend, peaking in September 2024, before moderating slightly. Self-funded and other receivables also showed a general upward trend throughout the period, suggesting growth in business activity and potentially changes in payment terms. The consistent growth in these receivables warrants monitoring for potential credit risk.
Goodwill and Intangible Assets
Goodwill consistently represented a large portion of noncurrent assets, remaining relatively stable between US$21 billion and US$29 billion. Other intangible assets also contributed significantly, with a similar pattern of relative stability, though with an increase towards the end of the period. The substantial value of these items suggests prior acquisitions and investments in intangible value.
Current vs. Noncurrent Assets
Current assets consistently represented a substantial portion of total assets, generally ranging between 45% and 55%. Noncurrent assets also contributed significantly, with a gradual increase over the period. The balance between current and noncurrent assets remained relatively stable, indicating a consistent long-term investment strategy.
Assets Held for Sale
Assets held for sale were only present in the period between June 2024 and December 2024, peaking at US$601 million in June 2024 and decreasing to US$490 million by December 2024. This suggests a discrete divestiture activity during that timeframe.

In summary, the asset composition demonstrates a focus on financial investments (fixed maturity securities) and intangible assets (goodwill and other intangibles). The fluctuations in cash and receivables suggest active financial management and business operations. The overall trend in total assets is positive, indicating growth, although the rate of growth has varied over time.


Assets: Selected Items


Current Assets: Selected Items